Category: Pharmaceuticals
Global Pharmaceuticals
-
Veterinary Vaccines
... at a CAGR of 5.7% over the analysis period 2023-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$4.7 Billion by the end of ... Read More
-
Human Vaccines
... at a CAGR of 7.3% over the analysis period 2023-2030. Intramuscular & Subcutaneous Administration Route, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by ... Read More
-
Poultry Chicken
... Thousand Metric Tons by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. The U.S. Market is Estimated at 28.1 Thousand Metric Tons While China is Forecast to Grow at 4.7% CAGR ... Read More
-
Connectors
... of 5.8% over the analysis period 2023-2030. PCB Connectors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$32.7 Billion by the end of the analysis period. ... Read More
-
Vitamins Market by Type (Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E, Vitamin K), Source (Natural, Synthetic), Application (Personal Care Products, Food and Beverages, Healthcare Products, and Others), and Region 2024-2032
... vitamins market size reached US$ 14.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. The market is ... Read More
-
Antidepressants
... of 2.5% over the analysis period 2023-2030. Antidepressants market for Major Depressive Disorder, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$7.0 Billion by the end ... Read More
-
Ophthalmic Pharmaceutical Drugs
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More
-
Pharmaceutical Contract Manufacturing
... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. API/Bulk Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$94.8 Billion by ... Read More
-
Electronic Data Capture
... by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Electronic Data Capture Services, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$1.4 ... Read More
-
Cardiology IT Workflow Solutions
... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Biopharmaceutical Bioseparation Systems
... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$15.8 Billion by ... Read More
-
Optical Coherence Tomography (OCT) for Ophthalmology
... the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected ... Read More
-
N95 Masks
... at a CAGR of 11.3% over the analysis period 2023-2030. Offline Distribution Channel, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.5 Billion by the end ... Read More
-
Healthcare Distribution
... at a CAGR of 13.9% over the analysis period 2023-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$2.3 Trillion by the end of ... Read More
-
Chiral Technology
... at a CAGR of 3.8% over the analysis period 2023-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$8.2 Billion by the end of the ... Read More
-
Multiple Myeloma Therapeutics
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$37.6 ... Read More
-
Kidney Dialysis Equipment and Supplies
... is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Hemodialysis Equipment and Supplies, one of the segments analyzed in the report, is expected to record ... Read More
-
Personal Finance Software
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by ... Read More
-
Protective Eyewear
... at a CAGR of 4.5% over the analysis period 2023-2030. Non-Prescription Protective Eyewear, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end ... Read More
-
Missiles
... of 4.7% over the analysis period 2023-2030. Surface-to-Surface Missiles, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$63.6 Billion by the end of the analysis period. ... Read More
-
Probiotic Ingredients Market Report by Ingredient (Bacteria, Yeast, Spore Formers), Form (Liquid, Dry), Application (Food and Beverages, Dietary Supplements, Animal Feed Probiotic), and Region 2024-2032
... in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.26% during 2024-2032. Probiotics refer to live microorganisms consumed for improving the functioning ... Read More
-
Global Varicella Virus Attenuated Live Vaccine Market Research Report 2024(Status and Outlook)
... Attenuated Live Vaccine Market Size was estimated at USD 3304.96 million in 2023 and is projected to reach USD 4822.41 million by 2029, exhibiting a CAGR of 6.50% during the forecast period. This report provides ... Read More
-
Metabolic Testing Solutions
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$324.1 Million by ... Read More
-
Deep Brain Stimulation Devices
... reach US$2.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Dual-Channel Deep Brain Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.0% ... Read More
Research Assistance
